EUCTR2010-022307-22-AT进行中（未招募）1 期
The Bergen-Stavanger-Innsbruck-Trondheim Study - Best Intro
Haukeland University Hospital, Division of Psychiatry0 个研究点目标入组 300 人开始时间: 2012年6月27日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •a) Patients 18 years and older
- •b) Psychotic symptoms compatible with the suffering from schizophrenia (F20, F21, F23.1, F23.2, F25), or paranoid psychosis (F22, F23.3).
- •(Psychosis will be defined by a score of 4 on one or more of the items: delusions, hallucinatory behavior, grandiosity, suspiciousness/ persecution, unusual thought content in the Positive and Negative Syndrome Scale (PANSS).
- •(This means that patients with symptoms matching the palette of schizophrenia or paranoid psychosis can also be included for a reliable diagnosis of schizophrenia-range / delusion suffering before a sufficient observation time has been fulfilled without drugs consumption.)
- •c) Patients, where antipsychotic drug treatment is indicated using the oral formulation of the drugs.
- •Patient does not take any antipsychotic drugs or shows the indication that the used antipsychotic should be replaced because the current antipsychotics were used long enough and in sufficient quantities without adequate effect, so that change is indexed to another antipsychotic, or the patient has serious side effects, why change is necessary, or the patient has decided to end the current antipsy-chotic treatment.
- •d) There is no indication to start a clozapine treatment.
- •e) Written and dated informed consent. (Austria only)
- •f) Female subjects of childbearing potential can be included, if they: agree to use, and be able to comply with, effective contraception without interruption, during the whole duration of participation (This applies unless the subject agrees to absolute and continuous abstinence) and agree to perform a pregnancy test at each study visit and 2 monthly pregnancy tests in the hospital between visit 5 and 6, 6 and 7 and 7 and 8.3
- •g) The patient is able to understand German. (Austria only)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 50
排除标准
- •a) Patients with organic psychosis (due to limbic encephalitis, Norway only) detected by antibodies in serum obtained at inclusion
- •b) Pregnant or breast feeding women
- •c) Concomitant antipsychotic drug treatment
- •d) Aripiprazole: Hypersensitivity to the active substance or to any of the excipients
- •e) Amisulpride: Hypersensitivity to the active ingredient or to other ingredi-ents of the medicinal product; Concomitant prolactin-dependent tumours e.g. pituitary gland prolactinomas and breast cancer; phaechromocy-toma; lactation.
- •Combination with the following medications which could induce torsade-de-pointes:
- •Class Ia antiarrhythmic agents such as quinidine, disopyramide, procainamide.
- •Class III antiarrhythmic agents such as amiodar-one, sotalol.
- •Other medications such as bepridil, cisapride, sul-topride, thioridazine, methadone, IV erythromycin, IV vincamine, halofantrine, pentamidine, sparflox-acin.
- •Combinations with levodopa.
- •e) Olanzapine: Hypersensitivity to the active substance or to any of the excipients; Patients with known risk of narrow-angle glaucoma; Combination with the following medications which could induce torsade-de-pointes:
- •Class Ia antiarrhythmic agents such as quinidine, disopyramide, procainamide.
- •Class III antiarrhythmic agents such as amiodar-one, sotalol.
- •Other medications such as bepridil, cisapride, sul-topride, thioridazine, methadone, IV erythromycin, IV vincamine, halofantrine, pentamidine, sparflox-acin.
- •Combinations with levodopa.
- •f) The patient is active in another clinical trial.
- •g) Inability to understand spoken Norwegian (Norway only)
研究者
相似试验
招募中
不适用
Bergisch Gladbach StudyI65.2I73.9Occlusion and stenosis of carotid arteryPeripheral vascular disease, unspecifiedDRKS00026095EVK Bergisch Gladbach5,000
已完成
不适用
The Brabant Study: a prospective cohort study among pregnant womethyroid dysfunction during pregnancy100437391001027310027946NL-OMON52874niversiteit van Tilburg4,000
进行中（未招募）
不适用
A PHASE II TRANSLATIONAL STUDY INVESTIGATING THE BIOLOGICAL EFFECTS OF THE ZOLEDRONIC ACID AS NEOADJUVANT THERAPY ON INVASIVE PROSTATE CANCER - THE JANUS TRIAEUCTR2009-014446-28-ITIVERSITA` CAMPUS BIOMEDICO
已完成
不适用
Berlin Initiative StudyN18I21Chronic kidney diseaseAcute myocardial infarctionDRKS00017058KfH-Stiftung Präventivmedizin2,069
招募中
不适用
Dutch BifUrcaTion Study Evaluating CHaracteristics of the Side Branch Opening with Optical Coherence Tomography after Side Branch FENestration in Patients Treated with COMBO or Xience Stent.NL-OMON48918Academisch Medisch Centrum30